Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f401a8a90cbead017d31972b7eff1c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6853 |
filingDate |
2018-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad0f330068597e377aafba11e1549239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9c8898dfbb34ccb53bc1f65afa9358b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dcd08c23ed81f780d904525729b7881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06dfdf9c7ce487ff0220c5a53d78e0a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c866983fc74fd9bf7d4e0fa7235877 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60f4bbcb3b3b9271ec9a2efce58b9deb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42252db18e729a061b95d981348110ba |
publicationDate |
2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3625364-A1 |
titleOfInvention |
Method for detecting genomic rearrangements |
abstract |
The present disclosure relates to methods for detecting and targeting genomic rearrangements, in particular gene fusion events, by targeting a DNA molecule of interest with a set or pool of primers, wherein the forward primers and reverse primers produce a PCR amplification product when a genomic rearrangement is present. The present disclosure also relates to methods of bioinformatic analysis to determine whether or not the detection of an amplification product from the selective PCR is actually indicative of the presence of a gene fusion. The present disclosure also related to related methods of diagnosis and treatment of diseases and conditions associated with such genomic rearrangements, in particular cancers, such as lung cancer. |
priorityDate |
2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |